Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meshach Asare-Werehene

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cells|October 27, 2022
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of ChemoresistanceToshimichi Onuma, Meshach Asare-Werehene, Yoshio Yoshida, et al.
The Journal of Applied Laboratory Medicine|March 2, 2026
Caught in the Gap: A Case of Unexpected Lactate ElevationMeshach Asare-Werehene, Emily Austin, Daniel R Beriault, et al.
Clinical Biochemistry|March 15, 2025
The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitisMeshach Asare-Werehene, Mary Kathryn Bohn, Allison Ming-Freckleton, et al.
Clinical Biochemistry|November 22, 2024
Discordance between creatinine and cystatin C-based estimation of glomerular filtration rate (eGFR) in solid organ transplant recipientsMary Kathryn Bohn, Meshach Asare-Werehene, Felix Leung, et al.
Cells|June 19, 2024
Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian CancerToshimichi Onuma, Meshach Asare-Werehene, Yuko Fujita, et al.
Plos One|January 13, 2026
RamanBot: Versatile high throughput Raman systemKhaled Atia, Robert Hunter, Meshach Asare-Werehene, et al.
BMC Cancer|May 26, 2020
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancerHideaki Tsuyoshi, Makoto Orisaka, Yuko Fujita, et al.
Journal of Ovarian Research|January 12, 2024
The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistanceHafiza Bushra Manzoor, Meshach Asare-Werehene, Satyajit Dey Pereira, et al.
Cancers|June 18, 2020
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas LigandChen-Tzu Chiu, Pei-Wen Wang, Meshach Asare-Werehene, et al.
Journal of Ovarian Research|May 22, 2021
COVID-19 in Africa: an ovarian victory?Osman A Dufailu, Afrakoma Afriyie-Asante, Bernard Gyan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cells|October 27, 2022
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of ChemoresistanceToshimichi Onuma, Meshach Asare-Werehene, Yoshio Yoshida, et al.
The Journal of Applied Laboratory Medicine|March 2, 2026
Caught in the Gap: A Case of Unexpected Lactate ElevationMeshach Asare-Werehene, Emily Austin, Daniel R Beriault, et al.
Clinical Biochemistry|March 15, 2025
The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitisMeshach Asare-Werehene, Mary Kathryn Bohn, Allison Ming-Freckleton, et al.
Clinical Biochemistry|November 22, 2024
Discordance between creatinine and cystatin C-based estimation of glomerular filtration rate (eGFR) in solid organ transplant recipientsMary Kathryn Bohn, Meshach Asare-Werehene, Felix Leung, et al.
Cells|June 19, 2024
Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian CancerToshimichi Onuma, Meshach Asare-Werehene, Yuko Fujita, et al.
Plos One|January 13, 2026
RamanBot: Versatile high throughput Raman systemKhaled Atia, Robert Hunter, Meshach Asare-Werehene, et al.
BMC Cancer|May 26, 2020
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancerHideaki Tsuyoshi, Makoto Orisaka, Yuko Fujita, et al.
Journal of Ovarian Research|January 12, 2024
The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistanceHafiza Bushra Manzoor, Meshach Asare-Werehene, Satyajit Dey Pereira, et al.
Cancers|June 18, 2020
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas LigandChen-Tzu Chiu, Pei-Wen Wang, Meshach Asare-Werehene, et al.
Journal of Ovarian Research|May 22, 2021
COVID-19 in Africa: an ovarian victory?Osman A Dufailu, Afrakoma Afriyie-Asante, Bernard Gyan, et al.
Pageof 3